Quadcap Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$602K Buy
24,984
+1,218
+5% +$31.9K 0.06% 252
2026
Q1
$667K Sell
23,766
-1,248
-5% -$33.2K 0.08% 220
2025
Q4
$623K Buy
25,014
+2,364
+10% +$59.6K 0.07% 228
2025
Q3
$577K Sell
22,650
-1,688
-7% -$41.7K 0.07% 240
2025
Q2
$590K Sell
24,338
-1,703
-7% -$39.7K 0.07% 231
2025
Q1
$660K Sell
26,041
-9,186
-26% -$240K 0.1% 200
2024
Q4
$935K Sell
35,227
-1,514
-4% -$41.1K 0.14% 142
2024
Q3
$1.06M Sell
36,741
-1,663
-4% -$48.5K 0.17% 125
2024
Q2
$1.07M Sell
38,404
-544
-1% -$15K 0.19% 116
2024
Q1
$1.08M Sell
38,948
-4,495
-10% -$125K 0.25% 93
2023
Q4
$1.25M Buy
+43,443
New +$1.31M 0.32% 79

Other funds holding PFE

Quadcap Wealth Management's PFE Position: Q2 2026 in Review

Quadcap Wealth Management increased its Pfizer (PFE) stake by 5.1% in Q2 2026, buying an estimated $31.9K and bringing the position to 24,984 shares worth $602K. The position accounts for 0.06% of the portfolio, ranked #252.

Quadcap Wealth Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.25M in Q4 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quadcap Wealth Management held 24,984 shares of Pfizer worth $602K as of Q2 2026.
  • Quadcap Wealth Management bought 1,218 Pfizer shares in Q2 2026, an estimated $31.9K.
  • Pfizer made up 0.06% of Quadcap Wealth Management's portfolio in Q2 2026, its #252 holding.
  • Quadcap Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Quadcap Wealth Management's Pfizer position peaked at $1.25M in Q4 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.